Leukemia: all 5,475 studies
Page 5 of 55. Open to participants first (629), then studies with results posted, then the rest; newest registration first within each.
- Ibrutinib for the Treatment of AIHA in Patients With CLL/SLL or CLL-like MBLRecruitingNCT05694312Phase 2
- MoleculAr Profiling for Pediatric and Young Adult Cancer Treatment Stratification 2RecruitingNCT05691608Not applicable
- Chidamide Prevents Recurrence of High-risk AML After Allo-HSCTRecruitingNCT05682755Phase 1/2
- ThisCART19A Bridging to alloHSCT for R/R B-ALLRecruitingNCT05679687Phase 1
- Reduced Intensity Conditioning Regimens for Acute Myeloid Leukemia and Myelodysplastic SyndromeEnrolling by invitationNCT05674539Phase 3
- Genetic Ablation of CD33 in HSC to Broaden the Therapeutic Index of CD33-directed Immunotherapy in Patients with AMLNot yet recruitingNCT05662904Phase 1
- HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological MalignanciesRecruitingNCT05658640Phase 1/2
- To Evaluate the Safety and Efficacy of Human CD19 Targeted DASH CAR-T Cells Injection for Subjects With R/R B-ALLRecruitingNCT05651191Early Phase 1
- CD19-Directed Chimeric Antigen Receptor (CAR) T-Cell Therapy for Relapsed/Refractory B-Lineage Leukaemia / Lymphoma - A Feasibility ProtocolRecruitingNCT05648019Phase 2
- Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular TherapyRecruitingNCT05646576Not applicable
- Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic LeukemiaRecruitingNCT05645718Phase 2
- Severe Toxicity Free Survival Following Childhood Acute Lymphoblastic LeukemiaRecruitingNCT05639673
- Testing the Use of Combination Therapy in Patients With Persistent Low Level Acute Myeloid Leukemia (AML) Following Initial TreatmentNot yet recruitingNCT05628623Phase 2
- Clinical Study of Senl-T7 CAR T Cells in the Treatment of Relapsed and Refractory CD7+ Acute T-ALL/T-LBLRecruitingNCT05626400Not applicable
- CD7 CAR-T Cells in T-cell Lymphoma/LeukemiaRecruitingNCT05620680Not applicable
- VCA Regimen Followed by D-MAG Regimen on the Treatment of Elderly Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)RecruitingNCT05603884Phase 2
- First-in-human Study Aiming to Characterize the Safety, Tolerability, Pharmacokinetic and Preliminary Signs of Activity of ABD-3001 in Refractory or Relapsed AML and High Risk MDS Adult PatientsRecruitingNCT05601726Phase 1/2
- Modified TBF Regimen as Conditioning Regimen Prior to Allo-HSCT for T-ALL/LBLRecruitingNCT05598593Phase 2
- CD5 CAR-T Therapy for Refractory/Relapsed CD5+ T-cell Acute Lymphoblastic LeukemiaRecruitingNCT05596266Phase 1
- Unrelated Umbilical Cord Blood Stem Cell Combined With Azacitidine Based Treatment for Advanced MDS,CMML-2 and sAMLRecruitingNCT05584761Phase 1/2
- Sulfasalazine in AML Treated by Intensive Chemotherapy: Elderly Patients-first Line TreatmentRecruitingNCT05580861Phase 1/2
- Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/LeukemiaRecruitingNCT05576532Phase 2
- Blinatumomab as a Bridge to Allo-HSCT in HR BCP-ALLRecruitingNCT05559450Phase 2
- Study of Management and Prognosis of Patients With Acute Myeloblastic Leukemia in Saint-Antoine HospitalNot yet recruitingNCT05558943
- Anti-CD30 biAb-AATC in Patients With Relapsed/Refractory CD30 Positive Hematopoietic MalignanciesRecruitingNCT05544968Phase 1
- Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)RecruitingNCT05536349Phase 2
- Clinical Study of Mitoxantrone Hydrochloride Liposome Injection in Subjects With Acute Myeloid LeukemiaRecruitingNCT05522192Phase 1/2
- Safety and Preliminary Efficacy of JK500 Cell Injection in Relapsed/Refractory Pediatric Acute Myeloid LeukemiaRecruitingNCT05519384Early Phase 1
- Clinical Study Protocol of Venetoclax Combined With Azacitidine and Harringtonine in the Treatment of sAMLRecruitingNCT05513131Phase 2
- Treatment With ABT-199 (Venetoclax) and Purine Analogues in Relapsed/Refractory Acute Myeloid LeukemiaRecruitingNCT05506332Phase 1
- Observational Study for the Evaluation of Incidence of Systemic Mastocytosis in t(8;21) Acute Myeloid LeukemiaRecruitingNCT05504408
- Safety and Efficacy of Expanded, Universal Donor Natural Killer Cells for Relapsed/Refractory AMLRecruitingNCT05503134Phase 1/2
- Use of Levocarnitine to Reduce Asparaginase Hepatotoxicity in Patients With Acute Lymphoblastic LeukemiaRecruitingNCT05501899Early Phase 1
- Effectiveness and Safety of Therapy Based on Attenuated ATO Plus Low-Dose ATRA in Patients With APLRecruitingNCT05497310Phase 1/2
- Study for Safety and Efficacy of Olverembatinib Combined With APG-2575 in Children With Relapsed/Refractory Ph + ALLRecruitingNCT05495035Phase 1
- Administration of Anti-siglec-6 CAR-T Cell Therapy in Relapsed and Refractory Acute Myeloid Leukemia (rr/AML)RecruitingNCT05488132Phase 1/2
- Studying Conditioning Regimen In Pediatric Transplantation - AML , SCRIPT-AMLRecruitingNCT05477589Phase 3
- Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic MalignanciesRecruitingNCT05476770Phase 1
- A Study of DR-01 in Subjects With Large Granular Lymphocytic Leukemia or Cytotoxic LymphomasRecruitingNCT05475925Phase 1/2
- Laser Therapy Effect on Oral Mucositis in Childhood Acute Lymphoblastic Leukemia PatientsRecruitingNCT05452668Not applicable
- SKLB1028, Daunorubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia (AML)RecruitingNCT05445154Phase 1/2
- Anti-FLT3 CAR-T Cell (TAA05 Cell Injection) in the Treatment of Relapsed / Refractory Acute Myeloid LeukemiaRecruitingNCT05445011Phase 1
- Treatment Free Remission (TFR) in CML Patients （CML-CP）StudyNot yet recruitingNCT05440747
- Follow-up Study on Chronic Myeloid Leukemia Patients Achieving Treatment-free RemissionRecruitingNCT05439889
- TAA05 Injection in the Treatment of Adult Patients With FLT3-positive Relapsed/Refractory Acute Myeloid LeukemiaRecruitingNCT05432401Early Phase 1
- Azacitidine in Combination With Low Dose Intensity Venetoclax in Patients With AML Incl. Explorative AML ProfilingRecruitingNCT05431257Phase 2
- Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage LeukaemiaRecruitingNCT05429905Phase 1/2
- Improving Communication and Building a Stronger Medical Home Among Spanish-speaking FamiliesRecruitingNCT05425992
- Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)RecruitingNCT05403177
- Allogeneic T Cells Expressing T Cell Receptor-KDEL and the Chimeric Antigen Receptor CAT19 for the Treatment of Advanced CD19+ MalignanciesRecruitingNCT05391490Phase 1
- Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen in Acute Myeloid Leukemia: Study Protocol for a Randomized Controlled TrialRecruitingNCT05382390Phase 3
- CD19 Chimeric Antigen Receptors and CD19 Positive Feeder T Cells as a Leukemia Consolidation TreatmentRecruitingNCT05381662Phase 1/2
- Polymorphism of ITGA4 Gene in Chronic Lymphocytic LeukemiaNot yet recruitingNCT05371392
- A Real World Study of the Efficacy and Safety of Flumatinib Versus Imatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic PhaseNot yet recruitingNCT05367765Phase 4
- cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual DiseaseRecruitingNCT05366881
- Ibrutinib Adapted to Response in Patients With CLLNot yet recruitingNCT05360758
- Evaluation of the Ambulatory Medical Assistance Nurse Program in Chronic Lymphocytic LeukemiaRecruitingNCT05350826Not applicable
- Pilot CAR-T Cells Therapy for Children/Young Adults With CD19+ R/R Leukemia/LymphomaRecruitingNCT05333302Phase 1
- The Patient Cohort of the National Center for Precision Medicine in LeukemiaRecruitingNCT05326919
- Natural Killer Cell Immunotherapy in Combination With PARP-inhibition in Acute Myeloid LeukemiaNot yet recruitingNCT05319249Phase 1/2
- Treateament of Newly Diagnosed Acute Monocytic Leukemia in ChildrenRecruitingNCT05313958Phase 2/3
- Combination of an Anti-PD1 Antibody With Tisagenlecleucel Reinfusion in Children, Adolescents and Young Adults With Acute Lymphoblastic Leukemia After Loss of PersistenceRecruitingNCT05310591Phase 1/2
- Clinical Trial to Evaluate the Safety and Efficacy of IM19 CAR-T Cells in Patients With Relapsed and Refractory (R/R) B-cell Acute Lymphoblastic LeukemiaNot yet recruitingNCT05309213Phase 1/2
- Venetoclax Combining Chidamide and Azacitidine (VCA) in the Treatment of R/R AMLRecruitingNCT05305859Phase 2
- Single-cell Dynamic Profiling in Adults With Newly Diagnosed Acute Myeloid Leukemia Treated With Intensive Chemotherapy. A THEMA Study"RecruitingNCT05304156
- Efficacy and Safety of Generic Imatinib (Carcemia®) Compared to Glivec® in Real-Life Management of Chronic Phase of Chronic Myeloid LeukemiaRecruitingNCT05282108
- Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic LeukemiaRecruitingNCT05281809Phase 2
- International Leukemia Target BoardRecruitingNCT05270096
- Venetoclax+HMA+Aclarubicin Versus Venetoclax+HMA in Treatment-Naive Elderly Patients With AMLRecruitingNCT05264883Phase 3
- Microtransplantation Combined With Azacytidine to Improve the Efficacy of EAMLRecruitingNCT05262465Not applicable
- Dual Growth Factor (rhTPO + G-CSF) and Chemotherapy Combination Regimen for Elderly Patients With Acute Myeloid Leukemia: A Phase II Single-Arm Multicenter StudyRecruitingNCT05258799Not applicable
- Venetoclax Resistance Landscape in Chronic Lymphocytic LeukemiaRecruitingNCT05246345
- A Study of HYML-122 in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)RecruitingNCT05241106Phase 2
- A Study of HYML-122 and Cytarabine in Patients With FLT3 Positive Relapsed or Refractory Acute Myeloid Leukemia (AML)RecruitingNCT05241093Phase 2
- Cognitive Aftereffects of Neurotoxicity in Children and Young Adults With Relapsed/Refractory Hematologic Malignancies Who Receive CAR T-cell TherapyRecruitingNCT05237986
- ADLs at the End of Acute Treatment for Childhood Leukemia and Non-Hodgkin LymphomaEnrolling by invitationNCT05235633
- A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell LeukemiaRecruitingNCT05219721Phase 1
- Clinical Study of Hospital-manufactured CD19 CAR-T in Children and Adolescents With Acute Lymphoblastic LeukemiaRecruitingNCT05210907Phase 1
- A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)RecruitingNCT05190471Phase 1
- A Study of IMM01 Combined With Azacitidine in Patients With Acute Myeloid Leukemia and Myelodysplastic SyndromeRecruitingNCT05140811Phase 1/2
- Selenious Yeast in CLL Patients w/o Indication of ChemotherapyRecruitingNCT05136378Not applicable
- RWE of Pediatric-like Protocol for AYA Patients With Ph-negative ALLRecruitingNCT05127148
- Analysis of the Immunobiology of Acute Myeloid Leukemia Relapses After Allogeneic Hematopoietic Stem Cell Transplant (HSCT) for the Generation of Guidelines and Personalized Therapeutic PathwaysRecruitingNCT05124288
- CD19 Targeted Universal Chimeric Antigen Receptor T Cells Injection for CD19+ Refractory/Relapsed B-cell MalignanciesRecruitingNCT05105867Early Phase 1
- Caloric Restriction and Activity to Reduce Chemoresistance in B-ALLRecruitingNCT05082519Phase 2
- Primary Plasma Cell Leukemia: a Prospective Phase 2 Study Incorporating Daratumumab to Chemotherapy and Stem Cell TransplantationNot yet recruitingNCT05054478Phase 2
- A Phase 1b-2 Trial to Assess Venetoclax and Navitoclax Consolidation and Post-transplant Maintenance in High-risk Patients With T-ALLNot yet recruitingNCT05054465Phase 1/2
- CART19 Cells Effects in Patients with Relapsed or Refractory Acute Lymphoblastic Leukemia and Non-Hodgkin's LymphomaRecruitingNCT05054257Phase 1
- Solving Riddles Through SequencingRecruitingNCT05046444
- CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic LeukaemiaRecruitingNCT05043571Phase 1
- ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia.RecruitingNCT05038696Phase 1
- Combined Immuno-chemotherapy for Patients With B-linear Acute Lymphoblastic Leukemia Diagnosed From 0 to 365 Days of Life (ALL-Baby-2021)RecruitingNCT05029531Phase 3
- Anti-FLT3 CAR T-cell Therapy in FLT3 Positive Relapsed/Refractory Acute Myeloid LeukemiaRecruitingNCT05023707Phase 1/2
- TAA05 Cell Injection in the Treatment of Recurrent / Refractory Acute Myeloid LeukemiaRecruitingNCT05017883Not applicable
- Neurocognitive Outcomes After Whole Brain Radiation Therapy for Hematologic MalignanciesRecruitingNCT05011045
- Venetoclax in Combination With Non-myeloablative Conditioning Allogeneic Haematopoietic Stem Cell TransplantationRecruitingNCT05005299Phase 1
- Clinical Study of DC-AML Cells in the Treatment of Acute Myeloid LeukemiaRecruitingNCT05000801Not applicable
- (Apex) Bezuclastinib in Patients With Advanced Systemic MastocytosisRecruitingNCT04996875Phase 2
- Bisantrene Combination for Resistant AMLRecruitingNCT04989335Phase 2
- Zebutinib Combined With Immunochemotherapy in the Treat of Newly Treated CLL Patients Without 17p-/TP53 MutationNot yet recruitingNCT04980859Phase 3